Australia's most trusted source of pharma news
Monday, 15 October 2018
Lost Your Access?
Too many meds, pharma blamed
Industry targeted for driving alleged over-diagnosis.
Lilly rushes new drug approval
Migraine access an 'immediate priority' says GM.
MA turns heat on non-members
Asks TGA to apply new advertising rules equally.
CSL chair ends time in sun
John Shine to hand over reins at Wednesday's AGM.
Should MSLs be accredited?
After huge growth, MSL body asks what's next.
Stada scores global gong
Named 'company of the year' by international publication.
PBS top five brands shuffle
New blockbuster bumps out old on PBS league table.
All equal in pharma say men
Industry has nailed equal opportunity for women, men say.
Aussie Pfizer boss rises higher
Former Aust MD continues climb in top level reshuffle.
Pharma pay joy hits high
Salary happiness up but what rise are workers tipping next?
Aust outdated, slow say bosses
AbbVie, Novo Nordisk, Janssen leaders warn of being left behind.
Aust to be CAR-T 'capital'
Health Minister promoting rapid introduction and manufacture.
Pfizer case leaves none wiser
All eyes on Sanofi as Pfizer settlement leaves questions hanging.
CSO past its use-by date: DHL
With tenders due to expire, CEO Resnick asks big questions.
What makes a good launch
First six month key says analysis of new drugs.
CSL gives $2.5m in local grants
Researchers into stroke and vaccines benefit.
More generics added
Alphapharm and Boucher & Muir drugs approved.
Janssen to expand Stelara
Filing shortly in US, EU for ulcerative colitis.
The path to change in Oz
Why the cowardly pharma lion needs courage.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design